A risky business: recalibrating the future of cardiovascular risk prediction in cancer survivors - Poll - MDSpire

A risky business: recalibrating the future of cardiovascular risk prediction in cancer survivors

  • By

  • Lorcan Ruane

  • Sivatharshini Ramalingam

  • Alexander R Lyon

  • January 30, 2026

  • 0 min

Share

Original Source(s)

A risky business: recalibrating the future of cardiovascular risk prediction in cancer survivors

  • by Lorcan Ruane, Sivatharshini Ramalingam, Alexander R Lyon

  • January 30, 2026

Related Content

Association Between Metabolic Clusters and Microbial Age in High-Risk Populations for Diabetes and Their Potential Impact on Cardiovascular Disease Risk: Cross-Sectional Observational Study

Prognostic value of CTI for major adverse cardiovascular events in patients With ST-elevation myocardial infarction after primary percutaneous coronary intervention

Quantitative CT assessment of intrathoracic visceral fat depots and their association with incident heart failure in asymptomatic adults